PL2611444T3 - Związki heterocyklilowe jako ligandy receptorów histaminowych H3 - Google Patents

Związki heterocyklilowe jako ligandy receptorów histaminowych H3

Info

Publication number
PL2611444T3
PL2611444T3 PL10803396T PL10803396T PL2611444T3 PL 2611444 T3 PL2611444 T3 PL 2611444T3 PL 10803396 T PL10803396 T PL 10803396T PL 10803396 T PL10803396 T PL 10803396T PL 2611444 T3 PL2611444 T3 PL 2611444T3
Authority
PL
Poland
Prior art keywords
histamine
receptor ligands
heterocyclyl compounds
heterocyclyl
compounds
Prior art date
Application number
PL10803396T
Other languages
English (en)
Inventor
Ramakrishna Nirogi
Anil Karbhari Shinde
Ramasastri Kambhampati
Rambabu Namala
Adi Reddy Dwarampudi
Laxman Kota
Murlimohan Gampa
Padmavathi Kodru
Taraka Naga Vinaykumar Tiriveedhi
Vishwottam Nagaraj Kandikere
Nageshwara Rao Muddana
Ramanatha Shrikantha Saralaya
Pradeep Jayarajan
Dhanalakshmi Shanmuganathan
Ishtiyaque Ahmad
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Publication of PL2611444T3 publication Critical patent/PL2611444T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL10803396T 2010-09-02 2010-11-15 Związki heterocyklilowe jako ligandy receptorów histaminowych H3 PL2611444T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2551CH2010 2010-09-02
EP10803396.0A EP2611444B1 (en) 2010-09-02 2010-11-15 Heterocyclyl compounds as histamine h3 receptor ligands
PCT/IN2010/000740 WO2012029070A1 (en) 2010-09-02 2010-11-15 Heterocyclyl compounds as histamine h3 receptor ligands

Publications (1)

Publication Number Publication Date
PL2611444T3 true PL2611444T3 (pl) 2016-03-31

Family

ID=43608695

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10803396T PL2611444T3 (pl) 2010-09-02 2010-11-15 Związki heterocyklilowe jako ligandy receptorów histaminowych H3

Country Status (26)

Country Link
US (1) US8912179B2 (pl)
EP (1) EP2611444B1 (pl)
JP (1) JP5650329B2 (pl)
KR (1) KR101538239B1 (pl)
CN (1) CN103079566B (pl)
AU (1) AU2010360038B2 (pl)
BR (1) BR112013005084A2 (pl)
CA (1) CA2812970C (pl)
CY (1) CY1117096T1 (pl)
DK (1) DK2611444T3 (pl)
EA (1) EA022746B1 (pl)
ES (1) ES2558531T3 (pl)
HR (1) HRP20151380T1 (pl)
HU (1) HUE028435T2 (pl)
IL (1) IL224652A (pl)
ME (1) ME02320B (pl)
MX (1) MX354852B (pl)
NZ (1) NZ607658A (pl)
PL (1) PL2611444T3 (pl)
PT (1) PT2611444E (pl)
RS (1) RS54514B1 (pl)
SG (1) SG188212A1 (pl)
SI (1) SI2611444T1 (pl)
SM (1) SMT201600012B (pl)
WO (1) WO2012029070A1 (pl)
ZA (1) ZA201301143B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2878217C (en) * 2012-08-23 2016-05-17 Suven Life Sciences Limited Acrylamide compounds as histamine h3 receptor ligands
CN104530088A (zh) * 2014-12-08 2015-04-22 苏州施亚生物科技有限公司 2-氨基-6,7-二氢-5H-噻唑并[5,4-b]吡啶-4-羧酸叔丁酯及其衍生物,以及它们的合成方法
EP3378477A1 (en) * 2017-03-21 2018-09-26 BIOPROJET Pharma New therapeutical use of h3-ligands
EA202091113A1 (ru) 2017-11-02 2020-08-28 Айкурис Гмбх Унд Ко. Кг Новые высокоактивные аминотиазолзамещенные индол-2-карбоксамиды, активные в отношении вируса гепатита b (hbv)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH23995A (en) 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4695575A (en) 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
WO2003004480A2 (en) 2001-07-02 2003-01-16 Novo Nordisk A/S Substituted piperazine and diazepanes as histamine h3 receptor agonists
MXPA05002575A (es) 2002-09-06 2005-09-08 Johnson & Johnson Compuestos heterociclicos.
EA200700254A1 (ru) * 2004-07-16 2007-06-29 Янссен Фармацевтика Н. В. Димерные производные пипередина
US20080015225A1 (en) * 2004-07-16 2008-01-17 Janssen Pharmaceutica N.V. Dimeric Piperidine Derivatives
KR20070113225A (ko) * 2005-03-14 2007-11-28 글락소 그룹 리미티드 히스타민 h3 수용체에 대해 친화성을 갖는 융합된 티아졸유도체
NZ570524A (en) * 2006-03-28 2011-08-26 High Point Pharmaceuticals Llc Benzothiazoles having histamine H3 receptor activity
WO2008012010A1 (en) * 2006-07-27 2008-01-31 Ucb Pharma, S.A. Fused oxazoles & thiazoles as histamine h3- receptor ligands
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US20080146559A1 (en) * 2006-12-08 2008-06-19 Li Chen 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives
US7557101B2 (en) * 2006-12-08 2009-07-07 Hoffman-La Roche Inc. 4,5,6,7-tetrahydro-thieno[3,2-c] pyridine derivatives
EA201001205A1 (ru) * 2008-01-24 2011-04-29 Юсб Фарма, С.А. Соединения, содержащие циклобутоксигруппу
WO2010026113A1 (en) 2008-09-03 2010-03-11 Evotec Neurosciences Gmbh Acyl- and sufonyl tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists

Also Published As

Publication number Publication date
EA022746B1 (ru) 2016-02-29
RS54514B1 (sr) 2016-06-30
DK2611444T3 (en) 2016-01-11
NZ607658A (en) 2014-02-28
CN103079566B (zh) 2015-06-17
MX354852B (es) 2018-03-22
CA2812970C (en) 2015-01-13
US8912179B2 (en) 2014-12-16
EP2611444A1 (en) 2013-07-10
KR20130042605A (ko) 2013-04-26
JP2013536834A (ja) 2013-09-26
JP5650329B2 (ja) 2015-01-07
ES2558531T3 (es) 2016-02-05
KR101538239B1 (ko) 2015-07-20
SI2611444T1 (sl) 2016-04-29
HRP20151380T1 (hr) 2016-01-15
IL224652A (en) 2016-05-31
ZA201301143B (en) 2013-10-30
EA201390327A1 (ru) 2013-08-30
AU2010360038B2 (en) 2014-05-15
BR112013005084A2 (pt) 2020-08-25
ME02320B (me) 2016-06-20
CA2812970A1 (en) 2012-03-08
WO2012029070A1 (en) 2012-03-08
EP2611444B1 (en) 2015-10-14
HK1180955A1 (en) 2013-11-01
US20140148440A1 (en) 2014-05-29
CN103079566A (zh) 2013-05-01
HUE028435T2 (en) 2016-12-28
AU2010360038A1 (en) 2013-04-04
SG188212A1 (en) 2013-04-30
MX2013001988A (es) 2013-05-09
SMT201600012B (it) 2016-02-25
CY1117096T1 (el) 2017-04-05
PT2611444E (pt) 2016-02-04

Similar Documents

Publication Publication Date Title
IL286152A (en) Modified imidazopyridinyl-aminopyridine compounds
AP3391A (en) 2-Amino-4-arylthiazole compounds as TROA1 antagonists
PL2611300T3 (pl) Podstawione skondensowane pochodne dihydropirymidynonów
IL225770A0 (en) Heterocyclic compounds
SI2648516T1 (sl) Substituirane spojine piridinon-piridinila
EP2709609A4 (en) HETEROCYCLIC COMPOUNDS
AP3307A (en) Heteroaryl compounds as 5-HT4 receptor ligands
ZA201306328B (en) Novel compounds as histamine h3 receptor ligands
IL232503A (en) H2 - Indazoles as antagonists of the ep2 receptor
IL232061A0 (en) A bicyclic heterocyclic compound
ZA201301143B (en) Heterocyclyl compounds as histamine h3 receptor ligands
IL236437A0 (en) Acrylamide compounds as ligands for the histamine h3 receptor
GB2501403B (en) 3-arylethynyl substituted quinazolinone compounds
ZA201409244B (en) Acrylamide compounds as histamine h3 receptor ligands
GB201015784D0 (en) Anti-cancer compounds
GB201021416D0 (en) Novel heterocyclic compounds
GB201009514D0 (en) Novel heterocyclic compounds
GB201109508D0 (en) Novel compounds